Korro Bio, Inc.
Key Metrics
Market Snapshot
About
Korro Bio is a biopharmaceutical company pioneering RNA editing therapeutics using proprietary OPERA (Oligonucleotide Promoted Editing of RNA) technology. The company's platform enables precise, programmable editing of RNA to correct disease-causing mutations and modulate protein function. Korro is developing treatments for genetic diseases affecting the liver, central nervous system, and other organs with high unmet medical needs.